Acarix A/S

Research Acarix A/S (ACARIX) on Bullrun: market cap SEK 289.04M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is SEK 289.04M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025SEK 7.36M-SEK 48.09M-SEK 49.14M84.7%-0.04SEK 18.22Mn/aSEK 38.17M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24SEK 289.04Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SEK.

About Acarix A/S

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Acarix A/S's market cap?

Acarix A/S's market capitalization is SEK 289.04M.

What does Acarix A/S do?

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.